Drugplain

CeraVe AM Facial Moisturizing Broad Spectrum SPF 30 Sunscreen 100 mg/mL

Homosalate, Meradimate, Octinoxate, Zinc Oxide, and Octocrylene · LOTION · L'Oreal USA Products, Inc.

No Recall History
Plain English

CeraVe AM Facial Moisturizing Broad Spectrum SPF 30 Sunscreen is a lotion containing homosalate, meradimate, octinoxate, zinc oxide, and octocrylene at 100 mg/mL, taken topical. Manufactured by L'Oreal USA Products, Inc..

Key Facts

Brand Name
CeraVe AM Facial Moisturizing Broad Spectrum SPF 30 Sunscreen
Generic Name
Homosalate, Meradimate, Octinoxate, Zinc Oxide, and Octocrylene
NDC Code (Product)
49967-015
Manufacturer
L'Oreal USA Products, Inc.
Strength
100 mg/mL
Dosage Form
LOTION
Route
TOPICAL
Marketing Status
Application #
M020
Marketing Start
08/03/2017

Recall History

No Recall History

Frequently Asked Questions

What is CeraVe AM Facial Moisturizing Broad Spectrum SPF 30 Sunscreen used for?

CeraVe AM Facial Moisturizing Broad Spectrum SPF 30 Sunscreen contains Homosalate, Meradimate, Octinoxate, Zinc Oxide, and Octocrylene. It is a lotion taken topical. Consult your doctor for specific uses.

Is CeraVe AM Facial Moisturizing Broad Spectrum SPF 30 Sunscreen a controlled substance?

CeraVe AM Facial Moisturizing Broad Spectrum SPF 30 Sunscreen is not classified as a controlled substance by the DEA.

What is the generic name for CeraVe AM Facial Moisturizing Broad Spectrum SPF 30 Sunscreen?

The generic name for CeraVe AM Facial Moisturizing Broad Spectrum SPF 30 Sunscreen is Homosalate, Meradimate, Octinoxate, Zinc Oxide, and Octocrylene. There are no other listed brand versions of Homosalate, Meradimate, Octinoxate, Zinc Oxide, and Octocrylene.

What is the NDC code for CeraVe AM Facial Moisturizing Broad Spectrum SPF 30 Sunscreen 100 mg/mL?

The NDC (National Drug Code) for CeraVe AM Facial Moisturizing Broad Spectrum SPF 30 Sunscreen 100 mg/mL is 49967-015, listed by L'Oreal USA Products, Inc..

Product NDC

49967-015

Package NDC

49967-015-01

Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.

Data from openFDA · Public domain (CC0 1.0)